Get started
Author

Sheila Dakhel Plaza

Observed names: Dakhel Plaza, Sheila, Plaza, Sheila Dakhel, S Dakhel, Sheila Dakhel
ORCID: 0000-0003-2546-6053
Observed ORCID: 0000-0003-2546-6053
OpenAlex ID: A5076594084
An ultra-high-affinity small organic ligand of fibroblast activation protein for tumor-targeting applications
2021 · Jacopo Millul, Gabriele Bassi, et al. · Proceedings of the National Academy of Sciences · 166
Therapeutic Targeting of Tumor Growth and Angiogenesis with a Novel Anti-S100A4 Monoclonal Antibody
2013 · Jose Luis Hernández, Laura Padilla, et al. · PLoS ONE · 102
PDF
S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer
2014 · S Dakhel, L Padilla, et al. · Oncogenesis · 63
PDF
S100A7: from mechanism to cancer therapy
2017 · L Padilla, S Dakhel, et al. · Oncogene · 57
Polypurine reverse Hoogsteen hairpins as a gene therapy tool against survivin in human prostate cancer PC3 cells in vitro and in vivo
2013 · Laura Rodríguez, Xenia Villalobos, et al. · Biochemical Pharmacology · 40
Immunotherapy with Immunocytokines and PD-1 Blockade Enhances the Anticancer Activity of Small Molecule-Drug Conjugates Targeting Carbonic Anhydrase IX
2020 · Jacopo Millul, Christiane Krudewig, et al. · Molecular Cancer Therapeutics · 18
PDF
An Attenuated Targeted-TNF Localizes to Tumors In Vivo and Regains Activity at the Site of Disease
2021 · Sheila Dakhel, Christian Lizak, et al. · International Journal of Molecular Sciences · 17
PDF
Targeted enhancement of the therapeutic window of L19-TNF by transient and selective inhibition of RIPK1-signaling cascade
2019 · Sheila Dakhel, Tiziano Ongaro, et al. · Oncotarget · 14
PDF
Identification and Validation of New Interleukin-2 Ligands Using DNA-Encoded Libraries
2021 · Adrián Gironda-Martínez, Émile M. D. Gorre, et al. · Journal of Medicinal Chemistry · 13
S100 to receptor for advanced glycation end-products binding assay: Looking for inhibitors
2014 · Laura Padilla, Sheila Dakhel, et al. · Biochemical and Biophysical Research Communications · 12
Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen
2023 · Louis Plüss, Frederik Peissert, et al. · mAbs · 11
PDF
Selection of a PD ‐1 blocking antibody from a novel fully human phage display library
2022 · Frederik Peissert, Louis Plüss, et al. · Protein Science · 11
Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2024 · Abdullah Elsayed, Louis Plüss, et al. · Molecular Cancer Therapeutics · 10
PDF
A novel strategy to generate immunocytokines with activity-on-demand using small molecule inhibitors
2024 · Giulia Rotta, Ettore Gilardoni, et al. · EMBO Molecular Medicine · 10
PDF
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties
2023 · Abdullah Elsayed, Christian Pellegrino, et al. · mAbs · 9
PDF
Ex vivo mass spectrometry-based biodistribution analysis of an antibody-Resiquimod conjugate bearing a protease-cleavable and acid-labile linker
2023 · Lydia Bisbal Lopez, Domenico Ravazza, et al. · Frontiers in Pharmacology · 7
Phenylalanine‐Based DNA‐Encoded Chemical Libraries for the Discovery of Potent and Selective Small Organic Ligands Against Markers of Cancer and Immune Cells
2025 · Francesca Migliorini, Andrea Ciamarone, et al. · Advanced Science · 6
PDF
Cytokine Biopharmaceuticals with “Activity-on-Demand” for Cancer Therapy
2024 · Giulia Rotta, Emanuele Puca, et al. · Bioconjugate Chemistry · 6
Combinatorial treatment with upadacitinib abrogates systemic toxicity of a tumor-targeted IL-2 fusion protein
2025 · Giulia Rotta, Eleonora Prodi, et al. · Journal for ImmunoTherapy of Cancer · 5
Isolation of a Natural Killer Group 2D Small‐Molecule Ligand from DNA‐Encoded Chemical Libraries
2022 · Sheila Dakhel, Andrea Galbiati, et al. · ChemMedChem · 3
Abstract 5744: Decreasing toxicity of immunocytokines by transient and selective inhibition of their intracellular signaling activation
2023 · Giulia Rotta, Ettore Gilardoni, et al. · Cancer Research · 2
Figure S1 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Movie S2 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Figure S2 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Figure S3 from Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
2026 · Abdullah Elsayed, Louis Plüss, et al.
Works count: 54
Citation count: 582
H-index: 11
I10-index: 14
Year
Topic
Type